HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief

This article was originally published in The Rose Sheet

Executive Summary

With the market for beauty products in Africa expected to grow, L’Oreal adds to its expanding business in East Africa with the launch of a subsidiary in Kenya. Market research firm Mintel suggests mature men would be more receptive to shaving product marketing than a younger consumer segment.

You may also be interested in...



Council Battles “Audit Fatigue” With GMP Program For Personal-Care Firms

The Personal Care Manufacturing Assessment Program, created by the Personal Care Products Council and SAI Global, covers quality assurance guidelines set out by internationally accepted ISO 22716 and addresses other areas of a company’s operations.

Fashion-Forward Lipstick Hues Spark Sales, Energize Young Consumers

Runway trends and hip new shades have consumers excited about lipstick again, driving up sales of lip products in U.S. department stores 7% for the first four months of the year, according to the NPD Group.

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017887

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel